Navigation Links
Nabi Biopharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference
Date:11/28/2007

ROCKVILLE, Md., Nov. 28 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI) today announced that Dr. Leslie Hudson, interim president and chief executive officer will participate in the BMO Capital Markets Focus on Healthcare Conference to be held December 4-5, 2007 at The Millennium Broadway Hotel in New York, NY. Dr. Hudson's presentation at the conference is scheduled for Wednesday, December 5 at 9:30 a.m. ET.

Dr. Hudson will present a company overview including a review of Nabi's corporate strategy and an update of its clinical development programs. A webcast of this presentation and webcast information can be accessed on the company's "Events and Webcasts" page at http://www.nabi.com or at http://www.bmocm.com/conferences/2007healthcare/ .

About Nabi Biopharmaceuticals

Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and, in certain areas, market products that target serious medical conditions in the areas of hepatitis and transplants, gram positive bacterial infections and nicotine addiction. We are a vertically integrated company with sales of antibodies and other biologics, including Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], a pipeline of products in various stages of development and a state-of-the-art manufacturing capability. The company operates through two strategic business units: Nabi Biologics and Nabi Pharmaceuticals. Nabi Biologics has responsibility for the company's protein and immunological products and development pipeline, including Nabi- HB. Nabi Pharmaceuticals is responsible
'/>"/>

SOURCE Nabi Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Mechanicsburg, PA (PRWEB) May 17, 2013 ... with ramp/soak capabilities. The 5R6-900 temperature controller has many ... can be plugged into the wall as a self-contained ... power supply. This distinctive detail makes the device unique, ... , The controller can also be used universally, which ...
(Date:5/17/2013)... May 17, 2013 - Elsevier, a world-leading provider of ... announced the publication of a recent study in ... human blastocysts showing that those with an abnormal chromosomal ... they have developed to blastocysts, thereby classifying the risk ... study the same group has undertaken a retrospective study, ...
(Date:5/17/2013)... -- New interactive learning forums will ... of the medical device industry at the 2013 ... from June 18-20 in Philadelphia ... ) , These all-new MedTech Innovate ... presentations and implementable solutions on the most cutting-edge ...
(Date:5/17/2013)... JOSE, Calif. , May 17, 2013 /PRNewswire-iReach/ ... agreement has been reached with Switzerland ... portfolio of anti-infective human monoclonal antibody (mAb) products, ... anti-infective human mAb products for treatment of infections ... of Staphylococcus aureus , Pseudomonas aeruginosa ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2Breakthrough for IVF? 2Breakthrough for IVF? 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... that a new market research report is available in ... Agreements http://www.reportlinker.com/p0471283/Biomarker-Partnering-Terms-and-Agreements.html ... and Agreements report provides comprehensive understanding and unprecedented access ... by the worlds leading healthcare companies. * ...
... for the future of industrial catalysis, as well ... as artificial photosynthesis, researchers with the U.S. Department ... Lab) have created bilayered nanocrystals of a ,metal-metal ... catalytic sites on nanocrystal interfaces. These multiple catalytic ...
... 2011 Tomophase Corporation, a leading developer of minimally ... today that it has installed the first of its ... Medical Branch (UTMB) in Galveston, Texas. This ... the laboratory of Dr. Massoud Motamedi, Director, Center for ...
Cached Biology Technology:Reportlinker Adds Biomarker Partnering Terms and Agreements 2Reportlinker Adds Biomarker Partnering Terms and Agreements 3Reportlinker Adds Biomarker Partnering Terms and Agreements 4Reportlinker Adds Biomarker Partnering Terms and Agreements 5Reportlinker Adds Biomarker Partnering Terms and Agreements 6Reportlinker Adds Biomarker Partnering Terms and Agreements 7Reportlinker Adds Biomarker Partnering Terms and Agreements 8Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces 2Berkeley Lab researchers report tandem catalysis in nanocrystal interfaces 3Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas 2
(Date:5/18/2013)... 18, 2013) Research presented at Digestive Disease ... health through diet and lifestyle. , Individuals ... reduced muscle strength, fatigue and poor quality of ... are in remission. A randomized, double blind, placebo-controlled ... D supplementation corresponded to significant relief of these ...
(Date:5/17/2013)... celebrate the science and technology of the region ... the inaugural Atlanta Science Festival, March 22-29, 2014. ... corporations, K-12 schools and universities, the festival will ... and adults at venues across the city. Learn ... annual Atlanta Science Festival is a collaboration of ...
(Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3First Atlanta Science Festival set for 2014 2
... This release is available in Spanish . ... are helping ensure that the smoked salmon that,s always a ... including among their achievements the development of a first-of-its-kind mathematical ... the optimal combination of temperature and concentrations of salt and ...
... at Houston (UTHealth) and BioHouston, Inc. on Oct. 21 ... entrepreneurs and new bio-tech start-ups in Houston. The ... nonprofits calls for greater collaboration between the organizations, technology ... saw the opportunity to expand wet lab facilities and ...
... are delivered head-first, but in about 4% of all ... or feet first. Doctors usually exercise caution and use ... for such births, believing it safer for the baby. ... the near-universal choice for such births. But now ...
Cached Biology News:USDA scientists helping keep in-demand smoked salmon safe to eat 2UTHealth, BioHouston sign collaborative agreement 2Breaching the breech protocol 2
Polaroid black & white positive, 3 x 4 inch pack film, ISO 3000/ 36 ASA DIN (20 expsures). For use in the Polaroid Direct Copy Camera (PHC34)....
Applications: (+) Immunocytochemistry and immunohistochemistry...
For the quantitative determination of canine Interferon gamma,(IFN-γ) concentrations in cell culture supernates, serum and,plasma....
Non-Protein Peroxidase Stabilizer , 1 L...
Biology Products: